Curio Wellness Establishes Cockeysville, Maryland, Medical Cannabis Facility
According to company officials, the 34,000 square-foot building will allow Curio to scale up production, keeping pace with the state’s rapidly growing medical cannabis industry while continuing its focus on research and development of targeted cannabis-based therapeutics.
“As the hub of production for our cGMP and award-winning products, the opening of our new product innovation site plays a significant role in furthering our mission to provide the accessibility of therapeutic medicinal cannabis solutions to patients across the state and beyond,” said Wendy Bronfein, co-founder, chief brand officer and director of public policy at Curio Wellness. “With this new facility, we look forward to maximizing our efforts in providing people with safe, effective and reliable products, while reaffirming our dedication to bringing a positive and tangible impact to Maryland’s economy.”
The facility’s role will be to produce the company’s quality medicinal cannabis products including Medicated Chews, Good Night, and Vape lines, as well as licensed products by Dixie, Wana, Kaviar and Mary’s Medicinals, exclusive to Curio Wellness. It will also serve as the home to production innovation and a research laboratory, furthering the company’s focus on targeted, scientifically developed medicinal products derived from cannabis.
2022 Top States for Doing Business Provide an Environment for Business Growth
36th Annual Corporate Survey: Executives Focus on Labor, Energy, Shipping Costs
Location Factors in the EV Industry — “Mission Critical” or “Nice to Have”?
2022 Auto/Aero Site Guide
Fixing the Supply Chain with AI and Robotics
Three Big Challenges Facing the Food & Beverage Industry
How Are Economic Developers Partnering to Solve Workforce Challenges?
The Form and Substance of Business Incentives